This study analyzed p16 overexpression in patients with oropharyngeal carcinoma and examined parameters such as gender, age, tumor site and stage, smoking, alcohol consumption, nodal stage, and, most importantly, survivability at 3 years and treatment evolution. This evidence concerns the gene CDKN2A and oropharyngeal carcinoma.